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Introduction 
 
Although overall drug use remains low among women, with men three times more likely than 
women to use cannabis, cocaine or amphetamines, women are more likely than men to misuse 
prescription drugs, particularly prescription opioids and tranquillizers (UNODC, 2015). In 
addition, as described later in the document, there are indications that this ‘gender gap’ might be 
closing among girls. Yet, as it will become clear, only a very limited number of substance use 
prevention strategies target girls specifically and it cannot be assumed that existing evidence-based 
substance use prevention strategies benefit girls as much as they do boys. Moreover, it is estimated 
that, while one out of three drug users is a woman, only one out of five drug users in treatment is a 
woman. (UNODC, 2015). 
The enjoyment of the highest attainable standard of health is one of the fundamental rights of 
every human being (WHO, 1946), and access to health care services should be provided on a basis 
of equality of men and women (UN, 1976). These principles have recently been re-iterated by the 
Member States of the United Nations in the context of the Sustainable Development Goals. 
Sustainable Development Goal 3 is to “ensure healthy lives and promote well-being for all at all 
ages”, and one of its targets is to “strengthen the prevention and treatment of substance abuse” 
(target 3.5). As all the Sustainable Development Goals are “integrated and indivisible”, the 
attainment Goal 3 and its targets should be accomplished together with Goal 5 to “achieve gender 
equality and empower all women and girls” (UN, 2015). The guidelines also respond to Resolution 
55/5 inviting “the United Nations Office on Drugs and Crime to work with relevant United 
Nations agencies, including the United Nations Interregional Crime and Justice Research Institute, 
to assist and support Member States in developing and adapting measures and strategies, at the 
national, regional and international levels, addressing the specific needs of women as an essential 
element of more effective, just and human rights-based policies;”. 
In this context, the overarching aim of this document is to inform and encourage governments, 
policy–makers, and other partners to take the necessary actions to implement evidence-based 
prevention strategies and treatment services for substance use disorders in order to provide 
everybody, girls as well as boys, and women as well as men, with the skills and opportunities to 
prevent the initiation of unhealthy behaviours and, in case of individuals who use drugs and suffer 
from drug use disorders, with the optimal support for improving their life circumstances. 
This document is a component of Project DAWN - Drugs, Alcohol and Woman Network, 
implemented by the United Nations Interregional Crime and Justice Research Institute (UNICRI) 
with the support of the Anti-Drug Policies of the Presidency of the Council of the Ministers of the 
Government of Italy. The aim of the project has been to establish a network of experts on gender 
differences in substance use and addiction recovery, who can advocate and assist in the 
development and implementation of evidence-based interventions, policies and best practices 
which are tailored to the particular needs of women. The network has been initially active in Italy 
(with the creation of the national network DAD.Net) and in the Mediterranean region in 
collaboration with the Pompidou Group. In addition, it has documented best practices in drug 
prevention and treatment (UNICRI, 2015) and, to complement this publication, UNODC has 
developed these guidelines.  
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Overview of the document 
The document first briefly discusses the alcohol and drug use prevalence and trends for girls and 
women worldwide, as well as the research on the factors of vulnerability and resilience that are 
specific to girls and women. The following section contains the results of a review of the literature 
on the effectiveness among girls and women of different kinds of drug prevention strategies and 
identifies indications on how to maximize their effectiveness among girls as much as among boys. 
The final section of the document summarizes current scientific evidence in a series of principles 
and guidelines on how to treat drug use disorders effectively among both girls and women.  
Methodologically, the content of the document has been developed on the basis of a summary of 
the scientific literature undertaken by two consultants in 2013. A draft of the guidelines was 
published in 2014 as a Conference Room Paper to the 57th Session of the Commission on Narcotic 
Drugs (E/CN.7/2014/CRP.12) and was shared with all the Member States of the United Nations, 
as well as with recognized scientists and practitioners in the field of prevention of drug use and of 
treatment, care and rehabilitation of drug use disorders. This final version takes into account the 
comment received in this context, as well as some major publications that appeared in the 
meantime.  
Scope and limitations 
The document attempts to provide guidelines to improve outcomes of drug prevention, treatment 
and care for girls and women. In this context, some limitations must be acknowledged. The first 
limitation is with regard to the lack of research in general. As it will become more clear in the 
following sections of the document, there exists many research gaps on how drug use and drug use 
disorders affect girls and women differently from boys and men and on how to address this 
phenomenon. Moreover, as it is the case in many other fields, research is overwhelmingly based in 
few high-income countries. In addition, even in the context of these countries, existing research 
explores the impact of other socio-economic characteristic only to a limited extent, e.g. 
marginalisation due to poverty and/or ethnic identity. Notwithstanding these serious issues, there 
exist at least some research available that the document attempts to summarise with a view to 
providing useful indications. 
Secondly, it is recognised that each culture possesses its own specificity in the way it assigns roles 
in the society to individuals born of female or male sex (gender roles). The document does not 
attempt an in-depth analysis of how gender roles shape the initiation and use of drugs, the 
development of drug use disorders and the relationship to prevention, treatment and care services. 
It should also be remembered that, in each culture, gender roles also vary accordingly to socio-
economic status, as well as the relation of the different ethnic groups within the society at large. A 
comprehensive analysis would need to take also these dimensions into account. Such an analysis 
would be of great benefit, but also of great complexity and is unfortunately beyond the scope of 
this document. In this context, the document limits itself to summarise the existing research as to 
differences in the epidemiology and aetiology of drug use and drug use disorders between girls 
and boys, as well as between women and men, as well as in the effectiveness of drug prevention 
strategies and drug treatment and care services. Even this basic analysis provide useful indications 
that, if implemented, monitored and evaluated, could result in better outcomes for girls and 
women.  
Finally, it should be noted that the document does not include examples of best and successful 
practices, as these have been already extensively presented in “Promoting a gender responsive 
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approach to addiction” (UNICRI, 2015), the collection of best practices examples published by 
UNICRI that is a companion to these guidelines.  
For clarification, there are several terms that were selected for use throughout the document. First, 
the term substance or drug use disorder was selected and has been uniformly used to indicate the 
spectrum of problems with substances for which women need to be provided with treatment and 
care services. This is both a scientific term and accepted nomenclature that encompasses the 
widest spectrum of problem substance use (APA, 2013). In this context, it should also be noted 
that the term ‘drug use’ is employed to refer to the use of drugs controlled by the three 
international drug conventions for non-medical purposes1. 
In general, it is understood that female children (0-10 years of age) and adolescents (11-18 years of 
age) are girls and older female individuals are women. These are to be considered broad indicative 
categories, as the issue of both chronological and developmental age, as well as cultural 
differences all need to be taken into account. Medically, puberty is the defining characteristic for 
categorizing females into girls or women. Before completing puberty a female is a girl. A female 
is a woman when she is physically an adult, and old enough to marry and bear children. Many 
cultures have rites of passage to symbolize a girl's coming of age, i.e. when she becomes a woman. 
Different cultures also recognize different ages of girls reaching sexual maturity or womanhood. 
Thus, the expected age of sexual initiation marriage and first childbirth varies by culture. It is 
important to note that while a girl may have the physical capacity for reproduction, it does not 
mean she has the emotional and mental maturity to consent to sex or marriage. These changes in 
chronological age as well as developmental age and corresponding cognitive abilities and cultural 
expectations need to be taken into account when planning and providing services for girls and 
women.  
                                                     
1
 Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol; Convention on Psychotropic 
Substances of 1971; and United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988. 
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I. Prevalence, trends and aetiology of 
substance and drug use disorders 
among girls and women  
 
This first section discusses the current use prevalence and trends in tobacco, alcohol and drug use 
in adolescents, with an emphasis on determining differences in use prevalence for girls as 
compared to boys. The general situation with regard to drug use and drug use disorders worldwide, 
as well as to the health and social consequences, has been exhaustively described in other 
publications and will not be repeated here.  
In general, compared with drug use among men, overall drug use remains low among women. At 
the global level, men are three times more likely than women to use cannabis, cocaine or 
amphetamines. By contrast, women are more likely than men to misuse prescription drugs, 
particularly prescription opioids and tranquillizers (UNODC, 2015). Globally, the gaps in 
reporting on the drug use situation are considerable and it should be considered that this is 
particularly the case with regard to girls and women, which are sometimes more difficult to reach. 
In addition, in many cases epidemiological tools do not take into account that women absorb and 
metabolize some substances differently and generally have less body mass than men. 
Epidemiological tools that do not use sex specific criteria (e.g. for ‘heavy episodic alcohol use’) 
underestimate the proportion of girls and women who engage in this behaviour (Poole et al., 
2014).  
Also among girls and boys, this traditional gender gap of prevalence being higher among boys 
than among girls appears to still largely exist. Figure 1 below summarises data from two different 
WHO surveys among students 13-15 years old indicating where the prevalence of lifetime 
cannabis (or drugs) use is significantly higher for boys, roughly the same or is significantly higher 
for girls. Although the data is not strictly comparable, as the surveys have taken place between 
2001 and 2013, it is useful to provide a general idea of the situation. 
However, substance use prevalence for girls has been increasing in the past two decades in some 
high-income countries, particularly with regard to the non-medical use of prescription drugs. In 
addition, in few countries (13 out of 82), the Global school-based student health survey (GSHS) 
was undertaken twice and in most cases for which the data is available (16 out of 23), the gender 
gap (i.e. the difference between the prevalence of a substance among boys and girls) has in fact 
been closing with prevalence among girls either decreasing less than the one among boys or 
increasing more. The following section provides a summary of the available data. As it will 
become clear, the gaps in the data are profound and allow only for a very general picture to be 
painted.  
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Figure 1. Higher or lower prevalence of lifetime use of cannabis 
(drugs) among boys and girls 
 
Note: LIGHTEST grey: prevalence among boys is higher than among girls, MIDDLE grey: prevalence among boys and 
among girls is approximately the same, DARKEST grey: prevalence among girls is higher than among boys. 
Source: GSHS National Fact Sheets (see references), HSBC report for the survey 2009/10, Secretaria de Salud, (2011). 
 
1. Africa 
The table below reports the data collected in various African countries by WHO through the 
Global School-based Student Health Survey. Although the surveys were undertaken in different 
years, this data is useful to provide a partial picture of the use of some substances in the countries, 
bearing in mind that these are percentages among the school population and 13-15-year old youth 
who are not in school are not represented. 
Table 1. Percentage of 13-15-year old students 
using various substances in African countries 
Country Drugs 
(used drugs once or 
more during 
their life) 
Alcohol 
(really drunk once or 
more during their life) 
Tobacco 
(smoked cigarettes on one or 
more days in the last 30 days) 
Year 
Girls Boys Girls Boys Girls Boys 
Benin 0.9% 1.5% 11% 14.3% 1.6% 3.3% 2009 
Botswana -- -- 17.4% 24.9% 14% 9.4% 2005 
Djibouti 6.7% 6.5% -- -- 2.8% 3.7% 2007 
Ghana 24.8% 24.6% 33% 32% -- -- 2007 
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Country Drugs 
(used drugs once or 
more during 
their life) 
Alcohol 
(really drunk once or 
more during their life) 
Tobacco 
(smoked cigarettes on one or 
more days in the last 30 days) 
Year 
Girls Boys Girls Boys Girls Boys 
Kenya 12.7% 13.5% 33% 24.4% 10.7% 17.3% 2003 
Malawi -- -- 2.3% 3.4% 3.8% 5.9% 2009 
Maldives -- -- 2.2% 6.1% 4.3% 13.9% 2009 
Mauritania 8.7% 7.3% -- -- 16.8% 17.2% 2010 
Mauritius 2.4% 8.9% 13.5% 20.8% 9.4% 23.3% 2011 
Namibia 26.6% 31.3% 28.9% 35.4% 14.2% 18.2% 2004 
Senegal 0.8% 1.7% 2.1% 6.6% 2.7% 9.1% 2005 
Seychelles 6.8% 19.6% 50% 56.2% 10.8% 24.1% 2007 
Swaziland 5.3% 10.3% 15.9% 23.7% -- -- 2003 
Tanzania 4.8% 6.8% 3.4% 7.5% 2% 5.3% 2006 
Uganda 7.5% 9.4% 13.9% 16.6% 2.6% 6.2% 2003 
Zambia 39.3% 36.7% 46.5% 38.6% -- -- 2004 
Zimbabwe 3.6% 12.1% 13.8% 19.4% 2.2% 9.6% 2003 
Source: GSHS National Fact Sheets as detailed in the references and as available online at 
http://www.who.int/chp/gshs/en/ 
In all these countries, tobacco, alcohol and drugs were used more by boys than girls. This is with 
the notable exception of the use of drugs in Djibouti, the use of alcohol and drugs in Ghana and the 
use of tobacco in Mauritania, the prevalence of which was fairly similar between boys and girls. In 
Zambia, both the use of drugs and alcohol was reported to be significantly higher among girls. It is 
not clear why this might be the case. However, this resonates with other data collected by WHO, 
reporting that in all African region countries, alcohol use in the past month was more common 
among boys, except the Seychelles (WHO, 2011). 
 
2. North America 
In the early 1990s, prevalence of current smoking (30-day, daily, and half pack or more per day) in 
USA rose more among boys than girls, and boys have reported consistently slightly higher 
prevalence since 1991 among 12th graders. In the lower grades, the genders have had similar 
smoking prevalence since their use was first measured in 1991, although in the past couple of 
years a small difference has emerged, with slightly more boys smoking than girls. Among college 
students, since about 2001 there has been little consistent gender difference in smoking among 
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college students (Monitoring the Future, 2011). In Mexico, among adolescents between 12 and 17 
years of age, boys still smoke twice as much as girls (Secretaria de Salud, 2011).  
Since the beginning of the US school-based surveys in 1975, called Monitoring the Future (MTF), 
boys have had slightly higher alcohol and drug use prevalence than girls. However, this gender 
gap has been narrowing in the past decades with 30-day alcohol use in girls being about 13% 
lower in 1975 than boys, but only 5% lower in 2012. When considering daily drug use including 
marijuana boys exceed girls’ use by two to three times among 8th, 10th, 12th grades. This is 
because in 2012, as in prior years, the rate of daily marijuana use in high school senior boys was 
almost three times higher at 9.1% for boys and only 3.6% for girls. However, if you consider drug 
use excluding marijuana, 8th and 10th grade girls’ use has been higher since first measured in 
1990. By 1995, 8th grade girls exceeded boys in their use of cigarettes, methamphetamines, 
amphetamines, cocaine, crack, inhalants, and tranquilizers and by 2002 in 30-day alcohol use. By 
2005 10th grade girls also exceeded boys in 30-day alcohol use until a slight decrease beginning 
four years ago.  
Eighth grade boys have higher prevalence of heavy drinking; however, in their 30-day prevalence 
of alcohol use at 8th grade, girls surpassed the boys in 2002 and have had higher prevalence since. 
At 10th grade, girls caught up to the boys by 2005, but boys have had higher 30-day prevalence of 
alcohol use for the past four years. Among 12th graders, the prevalence in 2011 were 18% for girls 
versus 26% for boys. This difference has generally been diminishing since MTF began; in 1975 
there was a 23-percentage-point difference, versus an 8-point difference in 2011. College males 
report considerably higher prevalence of daily drinking than college girls (6.2% vs. 2.3% in 2011). 
A similar gender difference also exists in the non-college group (6.3% vs. 3.8% in 2011). 
Frequent alcohol use tends to be disproportionately concentrated among boys. Daily alcohol use, 
for example, is reported by 2.9% of 12th-grade boys versus 1.2% of 12th grade girls. Boys are also 
more likely to drink large quantities of alcohol in a single sitting: 26% of 12th-grade boys reported 
drinking five or more drinks in a row in the prior two weeks versus 18% of 12th-grade girls. The 
rate among 12-17-year-old in Mexico was 17.3% for boys and 11.7% for girls (Secretaria de 
Salud, 2011). Girls in 8th grade showed about the same rate of being drunk in the prior 30 days as 
did boys (4.2% versus 4.4% for boys), whereas in 12th grade the rate for boys (28%) was higher 
than the rate for 12th-grade girls (22%).  
The annual prevalence for 12th-grade boys, compared to 12th-grade girls, are more than twice as 
high for hallucinogens, LSD, hallucinogens other than LSD, salvia, heroin, heroin with a needle, 
Rohypnol, GHB and steroids. In 8th grade, girls actually have higher prevalence of use for some 
drugs, including inhalants. Prevalence of amphetamine use are fairly close for both genders in all 
grades. Girls have higher prevalence of tranquilizer use in all three grades and this is of great 
concern given that the non-medical use of prescription or over-the-counter drugs to get high is 
second only to marijuana use (University of Michigan, Monitoring the future 2012). In the case of 
Mexico, boys (12-17) report twice as much use of any drug (2.2% including prescription drugs) as 
girls (1.1%) (Secretaria de Salud, 2011).  
 
3. Central America, the Caribbean and South America 
The table below reports the data collected in various countries of Central America, the Caribbean 
and South America by WHO through the Global School-based Student Health Survey. Although 
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the surveys were undertaken in different years, this data is useful to provide a partial picture of the 
use of some substances in the countries, bearing in mind that these are percentages among the 
school population and 13-15-year old youth who are not in school are not represented. 
Table 2. Percentage of 13-15-year old students using different substances in various 
countries of Central America, the Caribbean and South America 
Country Drugs 
(used drugs 
once or more 
during 
their life) 
Alcohol 
(really drunk once 
or more during 
their life) 
Tobacco 
(smoked cigarettes on 
one or more days in 
the last 30 days) 
Year 
Girls Boys Girls Boys Girls Boys 
Antigua and Barbuda -- -- 19.5% 26.1% 6.1% 8.2% 2009 
Argentina 6.5% 10.6% 26.8% 28.9% 20.5% 17% 2012 
Barbados 11.2% 17.8% 19% 29% 6.6% 12.7% 2011 
Belize 7.4% 15.6% 15.5% 21.1% -- -- 2011 
Bolivia 2% 2.9% 9.3% 12.8% 8.9% 15.7% 2012 
British Virgin Islands -- -- 20.7% 17.7% 4.3% 7.3% 2009 
Chile 9.3% 9.7% 21.1% 22.1% 33.5% 24.7% 2005 
Colombia 8.3% 13.7% 43.3% 47.2% 20.1% 20.2% 2007 
Costa Rica -- -- 15.6% 15.8% 8.4% 10.1% 2009 
Dominica -- -- 28.8% 37.6% -- -- 2009 
Ecuador 4.1% 7% 24.2% 31.2% 10.6% 14.5% 2009 
Grenada 7.8% 21.9% 22.1% 33.9% 3% 7% 2008 
Guatemala -- -- 8.8% 13.1% -- -- 2009 
Guyana -- -- 24.5% 34.7% 6.8% 17.4% 2010 
Honduras -- -- 10.6% 10.7% 11.1% 14% 2012 
Jamaica -- -- 27% 43.5% 16.9% 31% 2010 
Peru 1.9% 5.7% 10.2% 16.8% 11.9% 22.9% 2010 
Saint Vincent and the Grenadines 13.4% 26.9% 30% 40.3% 5.1% 12% 2007 
St. Lucia 15.8% 29.7% 30% 41.5% 6.2% 9.8% 2011 
Suriname -- -- 9% 21% 8.6% 12.5% 2009 
Trinidad and Tobago 3.8% 11% 22.2% 25.3% 6.9% 13.6% 2011 
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Country Drugs 
(used drugs 
once or more 
during 
their life) 
Alcohol 
(really drunk once 
or more during 
their life) 
Tobacco 
(smoked cigarettes on 
one or more days in 
the last 30 days) 
Year 
Uruguay -- -- 24.7% 24.5% 12.6% 8% 2012 
Venezuela 1.7% 4.7% 15% 25.5% -- -- 2003 
Source: GSHS National Fact Sheets as detailed in the references and as available online at 
http://www.who.int/chp/gshs/en/ 
Also in this region, the ‘gender gap’ appears to be largely the norm as in most countries the 
prevalence of use of substances among 13-15-year old students was significantly higher than that 
of girls. In a few countries, the picture was slightly different, with girls smoking significantly more 
than boys in Argentina, Chile and Uruguay and more or less the same in Colombia. With regard to 
alcohol, prevalence were reported to be similar between boys and girls in Chile, Costa Rica, 
Honduras and Uruguay. In another WHO survey, in Central America and the Caribbean, alcohol 
use in the past month was more common among boys, except Costa Rica (23.6% of girls vs 23.4% 
of boys), Saint Vincent and the Grenadines (53.5% of girls vs. 52.6% of boys) and Trinidad and 
Tobago (42.0% of girls vs.39.6% of boys) (WHO, 2011).  
 
4. Europe 
The average figures for lifetime, past 12-months and past 30-day alcohol use prevalence are about 
the same for adolescent girls and boys, but for more frequent drinking within each time frame, 
boys have higher consumption. Boys in most EU countries drink about one-third more than girls 
per drinking episode (2011 averages of 5.8 versus 4.3 centilitres of 100% alcohol). However in a 
couple of countries (Iceland and Sweden) the average quantities were about the same among girls 
as among boys. In a large majority of the countries, beer is the dominant beverage among boys. 
Spirits are the most frequently used beverages among girls in just over half of the European 
countries. 
The “heavy episodic drinking” in the past 30 days in girls had increased dramatically from 29% in 
1995 to 41% in 2007, but slightly decreased to 38% by 2011. Among boys this alcohol binge 
drinking rate was slightly higher in 2011 (43%) than in girls, and it has remained relatively stable 
since the 1995 rate of 41%. However, alcohol-related problems are more common among boys in 
terms of physical fights and trouble with the police. In a WHO survey, in most European countries 
and on average, the prevalence of being drunk more than once in a lifetime among 13-15-year-old 
students was still higher among boys than girls. However, 9 countries reported a higher prevalence 
among girls in 2010, compared to 4 in 2001. Moreover, in 25 out of 31 countries, the ‘gender gap’ 
narrowed between 2001 and 2010.  
There were small gender differences in 30-day cigarettes use in 2011. At the aggregate country 
level, the sex differences in 2011 were negligible for smoking in the past 30 days. So girls were 
smoking more since in 1995 and 1999 when slightly more boys were smokers. However, in 2011 
some individual countries had large sex differences with higher figures for girls in Bulgaria, 
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Monaco, France, Slovenia, Faroe Islands and Ireland and higher figures for boys in Albania, 
Cyprus and Moldova, Ukraine and Montenegro.  
In European teens, reported use of drugs varies considerably across the countries with higher 
lifetime experience reported by boys than girls (19 % vs 14 %) and drug use significantly higher 
for boys in 27 countries (EMCDDA, 2012).  
Annual cannabis use was reported as 15% among boys and 11% among girls, while 30-day use 
was reported by 8% of the boys and 5% of the girls. Regular 30-day marijuana use is higher in 
boys than girls (EMCDDA, 2012). Lifetime use of cannabis was reported by more boys (19%) 
than girls (14%), and the figures were significantly higher for boys in 27 countries. The average 
lifetime prevalence in 15-year-old students in the HSBC survey of WHO, which covers mostly 
European countries, fell a bit faster for boys (from 26% to 20%) than for girls (from 19% to 15%) 
between 2001/2 and 2009/10. 
While, more boys than girls have tried drugs other than cannabis, 7% versus 5% in 2011 
(EMCDDA, 2012), more girls (8%) than boys (5%) report non-medical use of prescription drugs. 
Lifetime use of tranquillizers or sedatives without a doctor´s prescription, together with mixing 
alcohol and pills, are the only substance-use behaviours that have been more common among girls 
than boys (EMCDDA, 2012). The use of inhalants increased equally in both sexes to 10% in 2011 
for the first time. 
 
5. North Africa and the Middle East 
The table below reports the data collected in various countries of North Africa and the Middle East 
by WHO through the Global School-based Student Health Survey. Although the surveys were 
undertaken in different years, these data are useful to provide a partial picture of the use of some 
substances in the countries, bearing in mind that these are percentages among the school 
population and 13-15-year old youth who are not in school are not represented. 
Table 3. Percentage of 13-15-year old students using different substances in various 
countries of North Africa and the Middle East 
Country Drugs 
(used drugs 
once or more 
during 
their life) 
Alcohol 
(really drunk 
once or more 
during their 
life) 
Tobacco 
(smoked 
cigarettes on 
one or more 
days in the last 
30 days) 
Year 
Girls Boys Girls Boys Girls Boys 
Algeria 0.3 4 -- -- 1.4 18 2011 
Egypt -- -- -- -- 1.4 5.8 2011 
Iraq -- -- -- -- 4.6 12.1 2012 
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Country Drugs 
(used drugs 
once or more 
during 
their life) 
Alcohol 
(really drunk 
once or more 
during their 
life) 
Tobacco 
(smoked 
cigarettes on 
one or more 
days in the last 
30 days) 
Year 
Jordan -- -- -- -- 7.6 17.7 2007 
Kuwait -- -- -- -- 7.5 23.7 2011 
Lebanon 1 6.3 16 27.1 -- -- 2011 
Libya -- -- -- -- 1.1 7.1 2007 
Morocco 1.3 4.1 -- -- 2.3 7.4 2010 
Qatar -- -- -- -- 10.8 25.3 2011 
Sudan -- -- -- -- 3.6 8.5 2012 
Syria -- -- -- -- 4.8 16.2 2010 
Tunisia 1.9 5.7 -- -- 2.7 12.7 2008 
United Arab Emirates -- -- -- -- 5.8 15.6 2010 
Source: GSHS National Fact Sheets as detailed in the references and as available online at 
http://www.who.int/chp/gshs/en/ 
In the countries of this region, less data was collected with regard to both alcohol and drugs. 
However, for those countries that did collect the data, and with regard to tobacco use, in all cases 
the prevalence among boys was significantly higher than the prevalence among girls.  
 
6. Asia 
The table below reports the data collected in various Asian countries by WHO through the Global 
School-based Student Health Survey. Although the surveys were undertaken in different years, this 
data is useful to provide a partial picture of the use of some substances in the countries, bearing in 
mind that these are percentages among the school population and 13-15-year old youth who are 
not in school are not represented.  
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Table 4. Percentage of 13-15-year old students 
using various substances in Asian countries 
Country Drugs 
(used drugs once or 
more during 
their life) 
Alcohol 
(really drunk once or 
more during their life) 
Tobacco 
(smoked cigarettes on one or 
more days in the last 30 days) 
Year 
Girls Boys Girls Boys Girls Boys 
Cambodia 1.2% 1.2% 2.9% 6.2% 2.4% 2.9% 2013 
China 0.7% 1.2% 4.8% 11.9% 2.4% 15.3% 2003 
Fiji -- -- 8.3% 17.3% 7.4% 16.2% 2010 
India -- -- -- -- 0.2% 1.9% 2007 
Indonesia 0.3% 0.6% 0.5% 4.8% 0.9% 22.1% 2007 
Kiribati 1.6% 6.8% 10.4% 35.4% 19.5% 34.4% 2011 
Malaysia 0.4% 1.4% 3% 6.8% 1.9% 14.3% 2012 
Mongolia 0.9% 1.5% 4.7% 8.5% 3.5% 8.3% 2013 
Myanmar 0.5% 0.4% 0.3% 2.6% 0.6% 3.4% 2007 
Nauru -- -- 15.9% 24.5% 24.5% 19.5% 2011 
Pakistan -- -- -- -- 1% 9.9% 2009 
Philippines -- -- 13.6% 17.8% 6.4% 18% 2011 
Tajikistan 0.7% 1.5% 0.5% 2% 0.6% 1.1% 2006 
Thailand 2.4% 15.8% 14.8% 25% 1.5% 10.8% 2008 
Vanuatu 1.9 5 5.8 10.3 8.2 19.4 2011 
Viet Nam 0.2 0.5 8.1 17.7 1.2 3.6 2013 
Source: GSHS National Fact Sheets as detailed in the references and as available online at 
http://www.who.int/chp/gshs/en/ 
Also in the Asian countries, the ‘gender gap’ is still substantially present, with a significantly 
larger percentage of boys using various substances than girls and with the exception of the use of 
drugs in Cambodia and Myanmar that, whilst low, is substantially similar between girls and boys.  
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II. Aetiology 
 
Currently, the reasons for different prevalence of the use of substances and drugs by girls and boys 
(generally lower in girls), as well as for the rise of substance and drug use in girls in some 
countries (particularly in earlier teens and with regard to some specific substances) remain unclear. 
However, this section summarizes the available evidence to provide some indications as to the 
factors that might make girls and boys vulnerable or resilient to start using substances and drugs, 
as well as to other risky behaviours. This chapter is not meant as an in-depth discussion of the 
aetiology of substance use disorders, as this would warrant a publication of its own. Rather, it will 
highlight where the factors of vulnerability and resilience between girls and boys and women and 
men differ.  
Several explanations for the gender gap in substance use have been advanced including the 
increased genetic risk in boys and recent family environmental risks in girls with rapid changes in 
social roles. Biological and socially constructed gender differences do appear to produce unique 
development trajectories for boys and girls, with concomitant vulnerability and resiliency factors 
that lead to different substance use behaviours and different motivations for using substances 
(Chesney & Pasko, 2004; Guthrie & Low, 2000).  
This section discusses different influences on substance and drug use starting with personal 
characteristics and moving into ‘micro’ influences close to the life of the individual (family, 
school, peers), as well as into ‘macro’ influences in the larger environment (social and physical 
dimensions of the community, the neighbourhood, the society at large).  
 
1. Personal characteristics 
There is evidence that boys have twice as high a genetic risk of alcohol dependency compared to 
women according to early twin adoption studies conducted in Sweden, Denmark and USA 
(Pickens et al, 1991). In certain Northern European families, there is a type of alcoholism called 
“Type II Alcoholism or Male Limited Alcoholism” characterized by early onset of use and many 
male relatives who become alcoholics (Vaillant, 1995). A study of college males with this family 
history and found that they had rapid brainwaves, increased emotional liability and autonomic 
nervous system (ANS) hyper- or over-reactivity (Schuckit, 2009). Consuming alcohol smoothed 
out their brainwaves and emotional over reactions. These genetic risks help to explain why 
addiction appears to be a “family disease” with children of parents with substance use disorders at 
much higher genetic risk.  
In addition, among the different personal characteristics that are linked to the initiation of 
substance and drug use and dependence, depression and aggressiveness in the first grade appear to 
have stronger predictive power for boys than girls, while conduct disorder and higher anxiety 
response have stronger predictive power for girls. Current research has not yet explained these 
differences. 
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Table 5. Vulnerability factors for drug use in adolescence as it relates to gender 
Vulnerability factors for drug use in 
adolescence that are more relevant 
for … 
Girls Boys 
Depression √  
Conduct disorder  √ 
Cigarette use √  
Maternal alcoholism √  
Maternal drug use disorder √  
Low parental attachment √  
Low parental monitoring  √  
Low parental concern  √  
Unstructured home environment √  
Dysfunctional family √  
Smoking During Pregnancy √  
Aggressiveness in first grade  √ 
Higher Anxiety Response √  
Peer Difficulties  √ 
Childhood Sexual Abuse √  
Source: Lee Wetheringtn (2012) 
High prevalence of comorbidity exist between substance use and depression in girls (Kloos et al., 
2009; Lillehoj et al., 2004). Substance abusing girls are more likely to be depressed than boys 
(Chander & McCaul, 2003). Likewise, depression leads to increased substance use disorders, 
reduced self-esteem, and increased suicide attempts for girls (Kloos et al., 2009). Girls who 
believe that drinking alcohol reduces depression report more alcohol use. More girls than boys (as 
young is the 6th grade) believe in self-medicating powers of alcohol to reduce depression, anger or 
frustration even before they begin to drink. Other drugs such as ecstasy and marijuana are also 
used by girls to reduce depression (Smith et al., 2002).  
Delinquency and substance misuse have been associated with low levels of self-esteem in teenage 
girls (Wild et al., 2004). Girls who at age 12 with low self-esteem were nearly 2.5 times more 
likely to engage in heavy alcohol use at age 15 than those higher in self-esteem; no such 
relationship was found in boys (Young et al, 2012; Emler, 2011). 
Finally, during puberty, both girls and boys must adopt new behaviours to comply with gender 
expectations inherent to their culture. Some girls experience low self-esteem and loss of "voice" as 
a result of social conditioning to suppress their self-expression as a means of maintaining 
important relationships (Spira, et al. 2002). 
15 
With regard to the development of substance use disorders, it is a medically established and widely 
recognised fact that substance use can progress into alcohol and drug use disorders more quickly 
for adolescent girls than for boys, even when using the same or lesser amounts of a particular 
substance.  
 
2. Micro-environment: family, schools and peers 
As indicated in Table 5, girls appear to be more affected by family problems than boys. This is 
also apparent in one of the few tested causal models by gender, the Social Ecology Model of 
adolescent vulnerability to substance use. Using Structural Equation Modeling (SEM) statistical 
analysis of a database of about 10,000 youth from multiple ethnicities in the USA, the researchers 
found that the pathways to drug use were fairly similar for girls and boys (CSAP, 2001; Kumpfer 
et al., 2003; Sales et al. 2003), with a strong pathway between family bonding and academic 
performance. 
Figure 1. - Social Ecology Model (SEM) of substance use by gender 
 
Note: In this chart F = girls and M = boys and the numbers are beta weights. 
The higher the number or size of the arrows, the stronger the causal influence. 
However, as it can be understood from Figure 1., the family pathway from parent/child bonding 
and attachment, to better parental supervision, to communication of positive family values and 
reduced substance use was stronger in girls than boys, whereas the community environment path 
was slightly stronger in boys. The final pathway to drug use collapsed into combining parental and 
peer values/norms as a factor because of the close association and was equally powerful for girls 
and boys. Lack of behavioural and emotional self-control had a slightly larger role in later drug use 
in boys, possibly because boys have a higher incidence of emotional and impulse control 
disorders. Girls were more influenced by their academic performance and self-efficacy than boys.  
A similar SEM model was tested for school failure, delinquency, and teen pregnancy as well as 
alcohol and drug use with similar results (Ary et al.,1999). Moreover, it has been found that low 
parental supervision had a greater influence on adolescent girls’ alcohol and drug use than on boys 
(Fothergill and Ensminger, 2006).  
Peer pressure may be more strongly associated with drinking for girls than it is for boys. Middle 
school girls who report high levels of peer pressure to drink are twice as likely to use alcohol than 
those who report less peer pressure; this relationship between peer pressure and alcohol is not 
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found for boys. When several of a girl´s closest friends smoke or drink, they are more than seven 
times more likely to drink and smoke, whereas, boys are only three times more likely. Finally, 
early maturing girls who have older friends appear to be a group at an elevated risk for substance 
misuse, truancy, delinquency and sexual activity (Caspi et al., 1993; Lanza & Collins, 2002). 
Sexual abuse and violence appears to be a stronger risk factor for girls and women, possibly due to 
the higher prevalence of victimization. One out of every three girls and women are victims of 
violence. The percentage of women in drug treatment facilities that were sexually abused as a 
child is high: 55% to 95% (Kumpfer & Bays, 1995). In the USA, the prevalence of sexual abuse 
was reported to be 60% for incarcerated adolescent girls and 20% for adolescent boys, with the 
prevalence of physical abuse being about 40% to 50% for both genders (Dembo et al., 2000). 
Finally, youth who misuse alcohol, marijuana, or drugs are at increased risk of victimization, with 
girls that use substances at particularly elevated risk of sexual assault (Testa & Livingston, 2009).  
 
3. Macro-environment 
Exposure to media messages that normalize or even glamourize drug and substance use, as well as 
to environment where psychoactive substances are easily accessible is a risk factor for both girls 
and boys. However, in many societies, girls are being exposed to media and societal pressures to 
conform to an unrealistically thin body ideal (Reel & Beal, 2009; Sypeck et al., 2004). 
Significantly more girls than boys begin using tobacco and drugs because they believe it helps 
them to keep their weight down. In the USA, the use of amphetamines among Caucasian girls is 
linked to the desire to lose weight (NCASA, 2003b). In general, reasons for girls´ use of harmful 
substances were found to include concerns about weight and dieting (NCASA, 2003a). Girls ages 
10 to 15 who report being highly concerned about their weight are nearly twice as likely to get 
drunk as those who are less concerned about their weight. Up to 50% of girls with eating disorders 
misuse alcohol or drugs compared to 9% of the general population and up to 35% of substance 
abusing girls also have an eating disorder (Piran and Gadalla, 2007). In another study, about 25% 
of US college women were skipping meals to save on calories and get drunk quicker. Girls who 
combine disordered eating with binge drinking are also more at risk for violence, risky sexual 
behaviour, alcohol poisoning, substance use and chronic diseases later in life, and cirrhosis of the 
liver (Baker et al., 2010). This phenomenon has also been reported in other countries of Latin 
America. Hispanic girls in the USA report disordered eating at higher prevalence than Caucasian 
or African-American girls.  
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III. Effective drug prevention among girls 
 
1. The scientific literature 
In the past twenty years research on the effectiveness of prevention strategies has reported that 
several programs demonstrate consistent positive findings when implemented completely and with 
fidelity (UNODC, 2013). While a variety of school-based, family-based and community-based 
programs have been effective at changing adolescent health behaviours, little is known on the 
effectiveness of these strategies by gender or on how programs can be tailored to be more gender-
aware or gender-specific (Blake et al., 2001; Fothergill & Ensminger, 2006). The few studies that 
have examined gender differences directly have found mixed results, with some showing effects 
among girls, but not boys and vice versa (Vigna-Taglianti et al., 2009, Flay et al., 2004). 
This chapter presents the results of a review undertaken in 2013 of two online databases of 
evidence-based programmes: the National Registry of Evidence-based Programs and Practices 
(NREPP) of the Substance Abuse and Mental Health Services Administration (SAMHSA) of the 
USA and the Exchange on Drug Demand Reduction Action (EDDRA) of the European 
Monitoring Centre for Drugs and Drug Addition. Each database includes programmes in 
accordance to established criteria with regard to the evaluation and, in the case of NREPP, also the 
results of the programme. The databases were searched for programmes categorised as 
‘prevention’, including universal, selective and indicated prevention. In turn, the results were 
searched for results disaggregated by gender. In addition, a questionnaire was sent to all the 
contact persons of drug prevention programmes as described above soliciting unpublished results 
disaggregated by gender. Only a few prevention program developers reported that they have 
conducted sub-group analyses for effectiveness by gender and the results are presented below. 
About one-third of those that did conduct analysis by gender found that boys and girls do, in fact, 
respond differently to prevention interventions.  
 
School- and community-based programmes 
The results with regard to the 11 school- and community-based programmes that conducted an 
analysis of the effectiveness by gender are reported in Table 6. Four (4) reported positive results 
for boys, but no significant positive results for girls, 1 reported positive results for boys, but 
negative results for girls, 3 reported positive results for girls, and 3 programs (Keepin’ it REAL, 
Al’s Pal and a culturally tailored intervention for Native American youth) reported no gender 
difference. Two (2) of the programs that worked for girls only (SMART and ALERT) reported 
results only for tobacco and cannabis. In addition, a school-based gender specific programme 
targeting female athletes (ATHENA) reported positive results for girls.  
In some cases these gender differences were only in sub-groups. In the case of ALERT, the more 
positive results for girls were only in high risk girls. The Keepin’ it REAL programme showed no 
overall gender difference for substance use. Subgroup analysis by ethnicity revealed gender 
effects, but only among less acculturated Latino youth. These gender effects were found for larger 
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positive changes in alcohol and cigarette use, and anti-drug norms among the boys, but not as 
much for girls.  
One of the programmes reporting no gender differences in results (Al’s Pals) was targeting a very 
young children and focusing heavily on their personal and social skills with a strong parenting 
component.  
The European Drug Abuse Prevention (EU-Dap) curriculum ‘UNPLUGGED’ is a school-based 
12-session teacher-led social skills programme for students including 3 meetings with parents. It 
was evaluated in seven European countries with 6,600 students. Baseline use prevalence revealed 
that boys were more likely than girls to have used cannabis and other drugs; whereas girls had a 
higher prevalence of cigarette smoking. There was a significant association between the 
programme and a lower prevalence of all behavioural outcomes, and a delay in onset of use. Boys 
benefited significantly more than girls, but both did have reduced frequency of use. 
Finally at the school level, ATHENA, a gender-specific programme for female high school 
athletes, was found to increase the knowledge of drug consequences and intentions not to use as 
well as decreasing use of drugs compared to a no-treatment control group (Elliot et al., 2002).  
At the community level, The 48 Community Partnership Cross-Site Study included a 10% sample 
of the 240 communities with a drug prevention coalition matched with a similar community in 
their state without a coalition. The results from this study revealed that statistically significant 
positive effects were found for 8th grade and 10th grade boys and adult men in reducing drug and 
alcohol use, but no positive effects for girls or women. In fact, a significant negative effect on 8th 
grade girl´s use of drugs was discovered (Yin & Ware, 2000). This may be due to the fact that 
these programmes tend to focus more on environmental policy changes like access to tobacco and 
alcohol for minors and enforcement of laws and ordinances that may have more of an impact on 
boys rather than girls.  
 
Family-based programmes 
Our survey of evidence-based prevention programs revealed that of the 7 evidence-based family 
programmes who had done a gender analysis all reported equally effective results for girls and 
boys and one reported better results for girls –Treatment Foster Care (see Table 7. below). In 
addition, 5 gender-specific family-based programmes for girls reported positive results for girls.  
A recent gender analysis of a large Strengthening Family Program (SFP) normative database of 
over 4,000 families from SFP groups worldwide found that SFP is equally effective for girls as for 
boys and in some cases even more effective for girls despite lower base prevalence of risk factors, 
possibly because girls are more influenced by family relationships (Magalhães, 2013). 
Of the three gender-specific programmes, randomized control trials of the mother-daughter 
substance use prevention programme delivered through CDs or internet showed good results for 
reducing HIV risk, alcohol and drug use among inner city Hispanic, African American and Asian 
American girls (Fang & Schinke, 2013; Schinke et al. 2009 and 2011; Schwinn et al., 2010). Two 
gender and ethnic adaptations of Strengthening Families Program 6-11 Years (SFP) targeting 
mothers and daughters also reported positive results for Hawaiians, (Kameoke, 1996) and Hispanic 
mothers and daughters (Alvarado, ***).  
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The general positive results of family-based programmes is consistent both with the brief 
discussion above of factors of vulnerability and resilience that are particular to girls, and with 
other general reviews of the effectiveness of family-based programmes (Petrie et al., 2007). 
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Table 6. Gender differences in outcomes of school and community-based prevention programs 
Name of 
programme and 
references 
Brief description of 
content 
Age group Dosage or 
number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference 
Better for 
girls 
Better for 
boys 
Self-Management 
and Resistance 
Training (SMART) 
(Graham et al., 
1990) 
Peer pressure resistance 
training and normative 
education, plus affective 
education, stress management 
and negative self-image 
enhancement. 
7th grade 
students 12 sessions Universal   
Tobacco 
Marijuana  
ALERT (Donaldson 
et al, 1994) and 
ALERT Plus 
(Longshore et al., 
2007) 
Drug prevention curriculum 
based on social learning 
theory. 
7th and 8th 
grades 
14 sessions, 
11 delivered 
in 7th grade 
and 3 in 8th 
grade 
Universal 
Tobacco: -0%; 
Alcohol: -0%; 
Cannabis: -4%; 
Other drugs: -
4% 
 
Tobacco and 
cannabis. 
NOTE: at 
risk girls 
only, no 
effect in 
boys. 
 
Oslo Youth Study 
Smoking Prevention 
Program  
Social influences-based 
smoking prevention program  
5th to 7th 
grades  Universal    
Tobacco, 
alcohol, drugs 
NOTE: Effects 
only on non-
smoking boys 
and no effect on 
girls  
North Karelia Youth 
Programme  
Is a school- and community-
based smoking prevention 
program using a social 
influence approach. Students 
are taught about social 
pressures and are trained by 
demonstration and role 
playing to deal with them. 
13-15 years 
10 sessions: 3 
in 7th grade, 5 
in 8th grade, 
and 2 in 9th 
grade. 
Universal    Tobacco, 
alcohol, drugs 
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Name of 
programme and 
references 
Brief description of 
content 
Age group Dosage or 
number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference 
Better for 
girls 
Better for 
boys 
Project Towards No 
Drug Abuse 
Students are educated on the 
consequences and 
misperceptions associated 
with drug use. Interactive 
sessions provide motivation 
and decision making skills 
targeting the use of cigarettes, 
alcohol, cannabis and other 
drugs, and violence related 
behaviour. 
14-19 years 12 sessions Universal 
Tobacco: -0%; 
Alcohol: -0%; 
Cannabis: -0%; 
Other drugs: -
4% 
  
Tobacco, 
alcohol, drugs 
Keepin’ it REAL 
(Kulis et al., 2007 
and 2005) 
Risk assessment, decision 
making, where to go for 
support, and communication 
skills such as conflict 
resolution and drug refusal 
skills. 
7th and 8th 
grades 10 sessions Universal 
Alcohol: - 11% ; 
Cannabis: - 5% 
No gender 
difference  
Better for boys 
in less 
acculturated 
Latinos 
European Drug 
Abuse Prevention 
(EU-Dap) 
curriculum 
‘UNPLUGGED’ 
(Fiaggano et al., 
***; Vigna-Taglianti 
et. al., 2009)  
Involves students in an 
interactive curriculum 
designed to improve and 
develop life skills, based on a 
comprehensive social 
influence model.  
12-14 years 
12 sessions 
for students 
plus 3 
sessions for 
parents 
Universal  Reduced alcohol 
and drug use.   
Reduced 
alcohol and 
cannabis best 
with some 
reduction in 
tobacco and 
other drugs. 
Best in boys 
and higher 
frequency users.  
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Name of 
programme and 
references 
Brief description of 
content 
Age group Dosage or 
number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference 
Better for 
girls 
Better for 
boys 
Al’s Pals: Kids 
Making Healthy 
Choices 
This is a resiliency-based, 
early-childhood prevention 
curriculum and teacher 
training programme that 
develops personal, social and 
emotional skills. It includes a 
component on building 
positive relationships between 
parents and children, which 
reinforces Al’s Pals concepts 
at home. It is designed to help 
children gain the skills they 
need in order to express 
feelings appropriately, relate 
to others, accept differences, 
use self-control, resolve 
conflicts peacefully, cope and 
make safe and healthy 
choices. 
3-8 years 
46 lessons 
lasting 10-15 
minutes each. 
Universal  
As effective 
for girls as 
for boys. 
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Name of 
programme and 
references 
Brief description of 
content 
Age group Dosage or 
number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference 
Better for 
girls 
Better for 
boys 
CASASTART 
 
This is a neighbourhood-
based, school-centred 
program aimed at preventing 
substance use and 
delinquency among high-risk 
adolescents and reducing 
drug-related crime in their 
neighbourhood, working with 
schools, law enforcement 
agencies, and social service 
agencies to create a network 
allowing every child the 
opportunity for healthy 
development. 
8-13 8 sessions Selective 
Cannabis: -
0.4%; Other 
drugs: -8.6% 
 
Negative 
effects for 
girls 
Positive effects 
for boys 
Culturally tailored 
intervention for 
Native American 
youth (Schinke, 
Tepavac & Cole, 
2000) 
Intervention was derived from 
a conventional theoretical 
model of life skills training 
and culturally tailored for 
Native American. 
Recruitment was done 
through schools. 
youth 
15 sessions 
each 50-
minute weekly 
with 2 booster 
50 minute 
sessions semi-
annually  
Universal 
3.5-yr sig. 
reductions in 6-
12 month 
alcohol, 
marijuana, and 
smokeless 
tobacco cigarette 
consumption.  
 
 
As effective 
for girls as 
for boys. 
  
ATHENA 
Targets female athletes 
improving nutrition and 
exercise to prevent drug 
misuse and eating disorders. 
Adolescents  Selective   
GENDER 
SPECIFIC 
with 
positive 
results for 
girls. 
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Table 7. Gender differences in outcomes of family-based prevention programs 
Name of 
programmes and 
references  
Brief description  Age 
group 
Number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference  
Better for 
girls 
Better 
for 
boys 
Family Matters 
(Bauman et al., 
2002) 
Parent education to make 
parents more aware of factors 
related substance use among 
adolescents.  
12-14 
years  
Four booklets mailed 
home with follow-up 
calls by health 
educators. 
Universal  
Tobacco: -7%; 
Alcohol: -6% 
3 & 6 months 
follow up 
indicated 
reduction in 
alcohol 
consumption & 
smoking 
As effective 
for girls as 
for boys 
  
Creating Lasting 
Family Connections 
(Strader) 
Programme designed for 
parents and youth which offers 
training modules for both. 
Content: communication, 
conflict resolution, peer 
resistance coping mechanisms 
to resist negative social 
influences; practice effective 
refusal skills for both parents 
and youth; engender self-
knowledge, personal 
responsibility, and respect for 
others; and impart knowledge 
and understanding about the 
use of tobacco, alcohol and 
drugs. 
Targeted 
couples 
are 18 
years of 
age or 
older 
10 sessions   
As effective 
for girls as 
for boys 
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Name of 
programmes and 
references  
Brief description  Age 
group 
Number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference  
Better for 
girls 
Better 
for 
boys 
Multisystemic 
Therapy for 
Delinquents and 
Substance Abusing 
Youth (Borodin, 
et.al, 1995; Haggler) 
Intensive family- and 
community- based treatment 
for juvenile offenders who 
have committed serious 
offences and their families. 
12 - 17 
years  
The course of 
treatment ranges from 
three to five months; 
the intensity of the 
treatment varies 
according to clinical 
need (from 2 to 15 
hours per week). 
Indicated 
Reduced 
substance use 
and criminal 
behaviour among 
young persons 
and the number 
of juveniles 
placed in care. 
As effective 
for girls as 
for boys.  
  
Multidimensional 
Treatment Foster 
Care Middle School 
Success 
(Chamberlain, P., 
***)  
A community-based 
alternative to placement in 
group or residential care for 
children and adolescents with 
severe emotional and 
behavioural problems. 
Coordinated interventions in 
the home, with peers, in 
educational settings, and with 
the child or adolescent’s birth 
parents, adoptive family, or 
other long-term placement 
resource. 
9-18 
years  6–9 months Selective 
Prevents ongoing 
delinquency, 
incarceration, 
and associated 
behavioural 
problems for 
adolescents. 
 
More 
effective for 
girls with 
regard to 
preventing 
tobacco, 
alcohol and 
drug use. 
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Name of 
programmes and 
references  
Brief description  Age 
group 
Number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference  
Better for 
girls 
Better 
for 
boys 
Strengthening 
Families Program 
(SFP), (Kumpfer, 
Magalhães, 2013) 
1. Parent skills training: goals, 
increasing positives, 
communication skills, and, 
effective discipline. 2. 
Children or teen skills 
training: goals, speaking and 
listening, peer refusal, anger 
and coping, etc. 3.Family 
skills training parent/child 
positive time, family meetings, 
chore charts, discipline 
practice sessions.  
 0-17 
Years  
Each session consists 
of the whole family 
attending 3 separate 1 
hour classes held on 
same night. Number 
of sessions varies by 
version, level of risk 
and age of the 
children from 7 to 14 
sessions. 
Universal 
and/or 
selective 
Tobacco: -7; 
Alcohol: -18%; 
Cannabis: -15%; 
Other drugs: -
11% 
As effective 
for girls as 
for boys.  
  
Multidimensional 
Family Therapy 
(Liddle, et al., 
2001,2009, 2011) 
MDFT is a manual-driven 
intervention with specific 
assessment and treatment 
modules for drug abusing 
youth. MDFT helps the youth 
develop more effective coping 
and problem-solving skills for 
better decision making and 
helps the family improve 
interpersonal functioning as a 
protective factor against 
substance use and related 
problems. 
12-18 
Years 
Delivered across a 
flexible series of 12 
to 16 weekly or twice 
weekly 60- to 90-
minute sessions,  
Indicated Decreased drug 
use 
As effective 
for girls as 
for boys. 
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Name of 
programmes and 
references  
Brief description  Age 
group 
Number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference  
Better for 
girls 
Better 
for 
boys 
Triple P: Positive 
Parenting Program 
(Sanders et al.) 
Parenting skills tiered 
programme targeting different 
level of risks and different 
ages. 
0-18 
Number and delivery 
of the sessions vary 
according to the level 
of risk ranging from 
media messages to 1 
– 10 group or 
individual sessions.  
Universal, 
selective 
and 
indicated. 
 
As effective 
for girls as 
for boys 
  
Incredible Years 
(Webster-Stratton) 
A curriculum each for parents, 
teachers and children, based 
on cognitive social learning 
theory, which emphasizes the 
importance of the family and 
of teacher socialization 
processes for young children. 
0-12 
Approximately 20 
sessions each for 
parents and children 
Universal, 
selective, 
indicated. 
 
As effective 
for girls as 
for boys 
  
Mothers and 
Daughters 
(Computer 
Mediated) 
Schinke, Cole, & 
Fang (2009) 
 
Gender-specific, online 
interactive program for 
mothers and daughters to 
complete. Dyads are recruited 
from Craigslist. Gift cards for 
survey completion. 
10-14 
9 web-delivered 35-
45 minute mother and 
daughter interactive 
lessons. 
Universal 
2-month follow-
up sig. 
reductions in 3-
6-12 month 
alcohol misuse. 
 
GENDER 
SPECIFIC 
FOR GIRLS 
with positive 
results 
 
Asian American 
Mothers and 
Daughters Program, 
Schinke, Cole, & 
Fang (2009) 
Fang & Schinke, 
2013. 
Online interactive program for 
Asian American mothers and 
daughters to complete. Dyads 
are recruited from social 
media and community 
agencies. Gift cards for survey 
completion  
10-14 
9 web-delivered 35-
45 minute mother and 
daughter interactive 
lessons. Average 5.8 
months to complete 
Universal 
2-yr sig. 
reductions in 3-
6-12 month 
alcohol, 
marijuana, and 
prescription drug 
misuse, but not 
smoking. 
 
GENDER 
SPECIFIC 
FOR GIRLS 
with positive 
results 
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Name of 
programmes and 
references  
Brief description  Age 
group 
Number of 
sessions 
Level of 
risk 
Effect on use 
by youth 
No gender 
difference  
Better for 
girls 
Better 
for 
boys 
Strengthening 
Family Program 6-11 
years (Kameoke, 
Alvarado) 
Two different culturally 
adapted family group 
curriculums for Hawaiian and 
Hispanic Families of the SFP 
(See description above). 
6-11 14 sessions Universal 
Improved social 
skills, decreased 
conduct 
disorders, 
depression and 
other risk factors 
 
GENDER 
SPECIFIC 
FOR GIRLS 
with positive 
results 
 
RealTeen program 
(Schwinn,Schinke & 
Noia, 2010) 
Gender-specific, interactive 
Internet based program. Girls 
were recruited through the 
youth-oriented website. 
9 theory-based sessions along 
with introduction and quizzes. 
13 -14 
years 
12 web delivered 25 
minute interactive 
sessions. Average 6 
weeks to complete at 
the rate of 2 sessions 
per week  
 
Universal 
 6-month follow-
up showed 
reduction for 30-
day 
alcohol use, 
marijuana use, 
poly drug use, 
and total 
substance use.  
 
 
GENDER 
SPECIFIC 
FOR GIRLS 
with positive 
results 
 
Mother daughter 
intervention among 
Black and Hispanic 
Adolescent Girls 
(Schinke, Fang, & 
Cole, 2009; 2011) 
Gender specific CD-ROM 
or internet based program for 
mothers and daughters. 
Recruited from postings on 
craigslist.org and from 
advertisements in New York 
City newspapers.  
10 -13 
years 
10 interactive 
sessions  Universal 
Post and 2 year 
outcomes 
indicated lower 
reports of girls' 
alcohol use 
and in their 
lower 
expectations of 
future tobacco, 
alcohol, and 
prescription drug 
use. 
 
GENDER 
SPECIFIC 
FOR GIRLS 
with positive 
results 
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2. Guidelines on preventing substance and drug use disorders 
among girls 
 
A gender-aware approach does appear to be necessary to prevent drug and 
substance use among girls and women 
Whilst the research base is very limited, it does point in the direction of the necessity of a gender-
attentive approach. There are factors of vulnerability and resilience that are specific to girls and 
women and there are indications that drug prevention strategies do not necessarily benefit girls and 
boys equally. A gender-attentive approach might implement gender-specific strategies for girls. 
Alternatively, it might try and insert components in universal programmes addressing factors of 
vulnerability and resilience that are specific to girls and women and to their development. In 
addition, the cultural adaptation research suggests that enrolment and retention can increase 
dramatically with adaptations (UNODC, 2009 family) and this might conceivably apply also in the 
case of gender.  
 
On the basis of the current research, family-based interventions appear to 
be a promising strategy to prevent drug and substance use as well among 
girls as among boys. 
The limited research indicates that, whilst family-based strategies are almost consistently 
providing as good effects for girls as for boys, school- and community-based strategies often fail 
girls. These results are also consistent with family factors of vulnerability and resilience with girls 
more affected by family problems and more protected by family bonding and supervision.  
 
Developing new strategies to respond to other factors of vulnerability and 
resilience that are specific to girls is crucial. 
As girls suffering from or at risk of depression and anxiety appear to be more vulnerable than boys 
with the same characteristics, it might be worth exploring programmes targeting girls screened for 
these factors and providing them with the skills to cope with negative emotions in a healthy and 
constructive way.  
This is based on the significance of low self-esteem, depression, anxiety and substance use by 
peers (particularly significant others) in the vulnerability of girls to drug and substance use. 
Moreover, topics to include in adolescent programming that might have a particular effectiveness 
for girls are: dealing with stress, depression, social assertiveness, body image and improving 
relations and communication with parents and other significant others. 
Modules on dating, meaning of love and sexual relationships, date rape, unwanted pregnancy, and 
sexually transmitted diseases would be helpful for young girls as well as boys. Having a time for 
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boys and girls to have their own separate groups, but then working together might be a good 
format to use in gender-specific prevention programmes. 
Given the importance of abuse, and particularly sexual abuse, as a very strong vulnerability factor 
in the development of substance use disorders, especially among girls and women, programmes to 
prevent such abuse and, particularly, to support the victims and to address post-traumatic stress 
disorders appear to be essential.  
Finally, the association between eating and substance use disorders in some countries would 
suggest some promising strategies with regard to addressing the factors of vulnerability of 
adolescent girls and women to eating disorders (such as societal pressures on girls and women to 
conform to unrealistically thin body ideals in some countries) and with regard to screening eating 
and substance use disorders concurrently. Such components could be conceivably included 
interventions in all major domains (school, media, community, family).  
Monitoring and evaluation are more essential than ever, including gender 
disaggregated data collection and analysis and the dissemination of results 
Worldwide, the effectiveness of only a very limited number of drug prevention strategies is 
evaluated and, of these, only a miniscule number collects data that are disaggregated by gender 
and conduct the relevant analysis. This means that in practice, we know very little about the 
effectiveness (or otherwise) of the vast majority of drug prevention interventions and policies that 
are implemented globally, let alone about whether they benefit girls as well as boys. Moreover, 
this serious situation is particularly the case (although it is by no means limited to) low- and 
middle-income countries. That is why any strategy aiming at preventing drug and substance use 
among girls and/or boys should include a systematic and scientific monitoring and evaluation 
component. In the case of non-gender specific programmes, this should include sex disaggregated 
data collection and analysis. For existing evidence-based programmes, secondary data analyses 
could be conducted on all major prevention program data sets to determine their effectiveness for 
girls as compared to boys. In all cases, results, including negative results, should be disseminated 
widely, for the benefit of the drug prevention community globally.  
 
Additional research is absolutely necessary 
The limited existing research provides some precious indications as to how to maximize the 
effectiveness of drug prevention strategies for girls as well as boys, but it is simply not enough. 
This should not prevent us from acting now. However, in addition to the systematic evaluation of 
interventions and policies as noted above, there is the absolute necessity of a deeper understanding 
of which factors of vulnerability and resilience are really specific to girls and women and whether 
and how this varies across cultures. Moreover, component analysis are needed to determine which 
aspects of the interventions contribute the most to the effectiveness for girls and boys. In general, 
we need to identify which aspects of the development, vulnerability and resilience factors and 
patterns of use of girls and women need to be addressed and how in order to be prevent drug use 
effectively among girls, or among girls as well as boys.  
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IV. Effective treatment, care and 
rehabilitation of substance use 
disorders for girls and women 
 
Unlike the case of prevention, an increased awareness of women's complex treatment needs in the 
context her substance use disorder led to the provision of funding for special services and 
programs designed specifically for women in the 1980s. By now there is an established corpus of 
scientific evidence and the purpose of this section is to summarize it in 10 basic principles, 
including specific guidelines for both girls and women. It should be emphasized that once in 
treatment, being biologically male or female does not predict drug dependence treatment outcome. 
However, several established predictors of drug dependence treatment outcomes may vary in 
prevalence, severity, or significance by sex, and these predictors may have a different level of 
importance for drug treatment outcomes for women than men. The general principles of evidence-
based treatment, care and rehabilitation are well established (UNODC/WHO, 2016) and will not 
be repeated here. 
 
1. Women-centred treatment: accessible, responsive to 
individual needs, strength-based, and with active patient 
involvement  
It is well established that girls and women have differences in the contexts in which they initiate 
drug use, maintain their drug use and enter treatment for such use. For example, girls and women 
are more likely to first try drugs in the presence of intimate male partners in their life. In contrast, 
boys and men more often start drug use in the presence of peer relationships. Women commonly 
begin using substances later in life than do men, report different reasons for maintaining the use of 
the substances, and enter treatment earlier in the course of their illnesses than do men (e.g., Brady 
and Randall., 1999). Women also tend to have a higher prevalence of comorbid psychiatric 
disorders (e.g., depression and anxiety) than men. Although women may present to treatment with 
more complex issues, women typically do as well as men in treatment.  
Research and clinical experience has shown that women and girls respond well to treatments that 
are women-centred. In fact, they have better treatment outcomes if they are in a women-only 
treatment rather than a mixed-gender program (e.g., Hser et al., 2011). A women-centred program 
is defined as having everyone in the program working to take into account the issues that girls and 
women face in their lives. These issues include, but are not limited to, challenges to treatment 
access and engagement. Specifically, women-centred treatment programs take into account social 
and structural barriers limiting accessibility to treatment services and acknowledge the fact that 
girls and women are both viewed as and serve the role of the predominant caregivers. Women-
centred care includes a trauma-informed program and provides trauma-specific interventions to 
women who have such needs. Each patient is seen to have her own unique strengths and 
vulnerabilities and treatment serves to promote her strengths and reduce vulnerabilities. Within a 
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woman-centred program, a patient is empowered to make informed decisions about her treatment 
and is actively involved in all aspects of her care. The principles of women-centred treatment 
shown below are based upon the premise that all health care practitioners will be sensitive to the 
needs of girls and women.  
 
Guidelines for adolescent girls 
Provide treatment to girls that is based on their developmental age, not just their 
chronological age.  
Youth treatment providers should be sensitive to the developmental differences among girls and 
make the necessary adjustments to accommodate such differences. The treatment of a 13-year-old 
girl should not be identical to that of an 18-year-old girl. For example, treatments that rely on more 
abstract thinking may not be as useful for girls who are just acquiring this type of thinking. 
General developmental features that tend to distinguish younger from older girls, as well as some 
guidelines pertaining to professional behaviour and attitudes that reflect these differences can be 
found in the Treatment of Adolescents with Substance Use Disorders: Treatment Improvement 
Protocol (TIP) Series 32 (Substance Abuse and Mental Health Services Administration, 2008). 
Girls need special attention in terms of their stage cognitive development, coping skills 
development and educational desires.  
Girls entering treatment for substance use disorders often present to treatment with a cumulative 
impact of psychological, health, and social consequences. Girls and boys may be poorly motivated 
for treatment and have problems in the domains of mental health, academics, family, and 
behaviour. They often have a limited range of coping and social skills. They may lag behind non-
drug using peers in achieving important developmental tasks, including individuation, moral 
development, and conceptualization of future educational, vocational, and family goals (Rutter, 
Giller, & Hagell, 1998). The complexity of the problems girls typically bring to treatment for 
substance use disorders underscores their need for multimodal treatment approaches that address a 
broad range of mental health and psychosocial problems beyond the treatment of the substance use 
disorder (Riggs, 2003).  
Based upon the developmental age of the patient, different services at different stages of 
her life are needed.  
For example, girls may need age-appropriate comprehensive sex education and youth-friendly 
sexual and reproductive health services. For girls in their reproductive years, they may need family 
planning and maternal health care as a part of treatment for substance use disorders. They may also 
need support in defining what healthy relationships are and how to minimize the likelihood of 
emotional, physical, and/or sexual abuse. 
Keep girls separated from boys in treatment.  
Programs for substance use disorder treatment need to recognize that mixing girls and boys within 
a program risks harms to girls, as they may be harassed, may feel less comfortable to talk openly 
about issues, and may feel less safe physically and emotionally in their treatment environment.  
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Identify multiple pressures girls have in their lives and help them develop positive coping 
mechanisms to address them.  
Girls who have a substance use disorder face unique challenges to their self-confidence, sense of 
personal power, and ability to process emotional issues. Girls tend to be more sensitive to family 
conflicts, and thus crave a stable social support network. Girls are more prone to depression than 
boys. Thus, each of these factors deserve consideration in developing a treatment plan that is 
responsive to each girl’s individual needs, building on her unique strengths and how to best 
actively engage her in the treatment process.  
Give girls the emotional support they need to feel physically and emotionally safe in 
treatment.  
Girls undergo different physical, social, and emotional changes than do boys and they are often not 
given adequate support to deal with these changes. Treatment can be a time for girls to have a safe 
space to develop and learn healthy behaviours that can promote transition into adulthood. 
Treatment goals need to be clear, dynamic and collaboratively set with the girl. 
Treatment will be most effective for girls when they take an active part in their treatment planning, 
when goals are achievable and made clear, and when they receive constructive feedback on their 
progress in treatment. 
 
Guidelines for adult women 
Create a treatment environment that empowers women.  
One overarching barrier that women face in accessing treatment for substance use disorders is that 
they may be living in very deprived circumstances. This deprivation is characterized by poverty, 
inadequate basic health care and reproductive care, low literacy rates, lack of access to household 
money and being victims of interpersonal violence. In some societies, women may have little 
power or resources to change their life circumstances. Women need to be empowered by society to 
take steps to change their life circumstances and minimize or eliminate the impact of gender 
inequality in their life. 
Review all structural aspects of the program to ensure as many barriers are minimized so 
that women can access treatment.  
Examples of structural barriers include the cost of treatment, the lack of treatment availability, and 
the lack of access to transportation to and from treatment, because treatment may not be located in 
an accessible part of her local community. Some programs refuse to accept patients who are 
concurrently treated for psychiatric disorders. This limitation may have a greater impact on women 
than men because women have higher prevalence of some psychiatric disorders such as anxiety, 
depression and posttraumatic stress disorder and greater prevalence of use of psychoactive 
medication. Many women with substance use disorders are at heightened vulnerability to 
interpersonal violence (e.g., women exchanging sex for food, drugs, housing and or clothing) and 
the lack of physical and emotional safety inside and outside the treatment program can be a barrier 
to entering and remaining in treatment. The treatment schedule also needs to be flexible so that 
treatment is compatible with her daily life activities. Women often have the primary childcare 
giving responsibilities and on-site childcare for women to bring their children while they are in 
treatment should be viewed as mandatory for any treatment program that is women-centred.  
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Train staff so that stigma, shame, guilt and fear can be quickly minimized for women in 
treatment.  
Examples of societal barriers that can impede women from seeking treatment for substance use 
disorders include stigma, shame, and guilt related to substance use disorders. Women with 
substance use disorders are typically more stigmatized than men with such disorders. This stigma 
from family, friends and society creates the context for shame and guilt that women experience 
about their substance use and their “failure” to live up to society’s expectations of being a good 
daughter, wife and mother. These feelings may be even greater for women engaged in commercial 
sex work due to the need for economic survival. In some societies, women have a real fear of 
losing custody of children.  
Women who are pregnant or parenting are often fearful of disclosing that they have a substance 
use problem and are seeking treatment. They have an often well-founded fear that they will be 
deemed an unfit mother and lose custody of their children. Women often lack of support from 
family and/or a husband/partner in their life. Studies have documented that women are more likely 
than men to have a substance using sexual partner and to have families of origin who have 
substance use problems. Because relationships play such a significant role in women’s lives, 
women living with a substance-using partner may be deterred from seeking treatment because they 
fear the loss of the relationship. In some cultures, women may be forbidden to leave their homes to 
go to treatment, or husbands may not support their wives leaving family and household 
responsibilities. In these circumstances, family members may only bring women to treatment when 
they are unable to fulfil their family responsibilities or are very sick.  
For many women, substance use serves as a way to self-medicate emotional problems or the 
experience of living in conditions of extreme distress. For example, some women are in 
relationships that are characterized by shared substance use, physical and sexual abuse, HIV and 
other infectious diseases and, sometimes, coercion into sex work and/or drug trade. In such 
situations, women may feel overwhelmed by their life circumstances and unable to see a way out. 
Research on women’s perceptions of treatment indicates that some women feel that they can 
handle the problems themselves and/or lack confidence in the effectiveness of treatment. When 
treatment is made more women-centred, the effectiveness of treatment can be improved. 
Treatment goals need to be clear, dynamic and collaboratively set with the woman. 
Treatment will be most effective for women, when they take an active part in their treatment 
planning, when goals are achievable and made clear and when they receive positive feedback on 
their progress in treatment. 
 
2. Treatment that is based on theory and evidence 
The most effective treatments for substance use disorders are those treatments that have a 
foundation in theory, because theory provides a framework for all aspects of patient care. 
However, even treatments provided based on a theoretical framework need to have accumulated 
scientific knowledge, an evidence base, to support their use. The high standard of an evidence base 
for many medical disciplines (e.g., cardiology) needs to be applied uniformly in the drug 
dependence field. It is important to note that while treatments have been found to be efficacious 
for girls and women, the majority of the research on substance use disorders and their treatment 
has been conducted with men. Among the research on women, much of this literature is focused 
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on pregnant and parenting women. Thus, future research needs the active involvement of women 
researchers and a focus on girls and women of all age ranges and across the life span. 
 
Guidelines for adolescent girls 
Pharmacotherapy to treat substance use disorders should be used with girls only after carefully 
evaluating and discussing with the girl the risks and benefits of the medication. Many medications 
commonly used to treat adult substance use disorders have not been studied in controlled trials 
with adolescents. There is some support for the use of opioid agonist, especially methadone in 
adolescents when they are considered able to consent to such treatment and it should be used for 
adolescents with severe drug use disorder and high risk for continuing drug use. The consent 
should be provided also by the parents and in compliance with national legislative policies. 
Adolescents with a short duration of opioid use disorder who have a lot of family and social 
support may respond to opioid withdrawal with or without naltrexone as a relapse prevention 
strategy. Appropriate pharmacotherapy should also be used to treat co-occurring psychiatric 
disorders as a part of integrated treatment plan that also involves psychosocial treatments 
(UNODC, 2016). If medications are used in treating adolescents, they must be used with caution, 
careful monitoring, and consideration of the developmental characteristics that distinguish girls 
from women, such as developing hormones, brain development, greater impulsivity and polydrug 
use (Riggs, 2003).  
Evidence-based psychosocial interventions are effective and expected standards of 
treatment for substance use disorders. ` 
Research on psychosocial interventions for adolescents with substance use disorders has made 
significant advances in the past decade. Controlled trials now provide good evidence that several 
psychosocial treatment approaches can be effective in treating girls and boys with substance use 
disorders and other associated problems. Several of these interventions are based on modalities 
that have been effectively used with adults and modified substantially to make them 
developmentally appropriate for adolescents (Deas, Riggs, Langenbucher, Goldman, & Brown, 
2000; Drug Strategies, 2002; Wagner, Brown, Monti, Myers, & Waldron, 1999). Behavioural 
therapy has been shown to help adolescents become drug-free and to improve problems in other 
areas, such as employment, school attendance, family relationships, conduct problems, and 
depression (Azrin, Donohue, Besalel, Kogan, & Acierno, 1995; National Institute on Drug Abuse, 
1999).  
Family-based interventions should be used with girls as a component of treatment for 
substance use disorders.  
Family based interventions include structural strategic family therapy, parent management training 
(PMT), multisystemic therapy (MST), and multidimensional family therapy (MDFT). They are 
based on family systems theory and share the assumption that dysfunctional family dynamics 
contribute to adolescent substance use disorders and related problems. In practice, clinicians 
perform a functional analysis to identify problem behaviours, and relationship patterns that are 
then targeted with restructuring interventions. Parents are taught better monitoring skills and basic 
behavioural management principles to improve their adolescent’s behaviour and reduce drug use 
together with strategies to improve overall family functioning and sustain the gains of treatment 
(Drug Strategies, 2002; Wagner et al., 1999). 
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Cognitive-behavioural therapy can be used with girls.  
Cognitive-behavioural therapy based on learning theory, also has been shown to be effective in 
treating adolescent substance use disorders (Drug Strategies, 2002; Wagner et al., 1999). Evidence 
exists to support both girls and women benefitting from cognitive-behavioural intervention 
approaches where there is a functional analysis of substance use (e.g., understanding substance use 
as it relates to the antecedents and consequences of substance use) and training patients in skills to 
support abstinence (e.g., recognize and avoid times or occasions when there is a risk of substance 
use and learn and apply coping skills if avoidance of these situations is not possible) (Carroll, 
1998). Despite the emerging empirical support for use of cognitive-behavioural therapy among 
girls and women, additional research is needed to best understand how it works for special 
populations. 
Motivational enhancement therapy can be a helpful adjunct to treatment but should not 
be used as a stand-alone treatment for girls.  
Motivational enhancement therapy has been used both as a stand-alone, brief intervention (for 
example, among adolescents presenting to emergency rooms with alcohol-or drug-related injuries) 
and integrated with other modalities such as cognitive-behavioural therapy (Monti, Barnett, 
O'Leary, & Colby, 2001) 2001). Recent controlled trials indicate that treatment of co-morbid 
psychiatric disorders alone is not likely to significantly reduce substance use or induce abstinence 
in dually diagnosed adolescents e.g., (P.D. Riggs, Mikulich, & Hall, 2001)].  
 
Guidelines for adult women 
Women’s treatment needs to address women's specific needs. 
These include childcare assistance, pregnancy, parenting, interpersonal violence, sexual trauma 
and victimization, psychiatric co-morbidity, housing, income support, and social services. To date, 
most substance use treatment models have been designed for men and based predominantly on 
evidence from research with male participants. However, gender-specific interventions that are 
designed to deliver information and services tailored for women are beginning to emerge in 
response to mixed-gender programs, which often fail to address women's specific needs, such as 
childcare assistance, pregnancy, parenting, interpersonal violence, sexual trauma and 
victimization, psychiatric co-morbidity, housing, income support, and social services (Orwin, 
Francisco, & Bernichon, 2001).  
Pregnant women should not be turned away from treatment for substance use disorders.  
In a meta-analysis examining single-gender treatment of women, Orwin and colleagues (Orwin et 
al., 2001) concluded that single-gender treatment was effective and its strongest effect was on 
pregnancy outcomes, psychological well-being, attitudes/beliefs, and HIV risk reduction. 
Additional research is needed to determine which women will benefit from which 
treatments.  
Additional research is also necessary to elucidate gender differences in response to specific 
pharmacotherapy and behavioural treatments, to identify subgroups of women who can benefit 
from single-gender versus mixed-gender treatments, and to improve understanding of the 
effectiveness and cost-effectiveness of gender-specific versus standard treatments (Greenfield et 
al., 2010). 
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3. Staff demonstrating respect and empathy for their patients 
All staff working with girls and women need to have the appropriate training, experience and 
qualifications to work with girls and women who have substance use disorders. While this 
background is critical for treatment, it is equally important to interact with patients in ways that are 
respectful. Being respectful entails explicitly stating and maintaining the boundaries of patient 
confidentiality and allowing patients to be autonomous, and have control over all aspects of her 
care. The staff needs to work with an orientation of justice, beneficence, and without maleficence. 
Patients respond best to staff who demonstrate empathy, the ability to see the patient’s views, and 
create a treatment program that responds to these views. Program leadership has the responsibility 
of ensuring that staff receives appropriate training, supervision, and ongoing support for 
maintaining respect and empathy. Ideally staff should be trained and skilled in the unique needs of 
girls and women; however, if the staff lacks such training, this absence of training should not be 
used as a reason for excluding girls and women from treatment. There is a need to balance 
adequate training with the need to provide services to girls and women. 
 
Guidelines for adolescent girls 
Treatment providers must be sensitive to motivational barriers to change at the outset of 
intervention. 
There are several strategies suggested by Miller and Rollnick for encouraging reluctant clients to 
consider behavioural change (Miller and Rollnick, 1991). 
The style and personality of the health care provider and the philosophy of care are 
considered to be very important in the care of girls with substance use disorders.  
The clinician needs to be genuinely interested in girls as individuals first, then in their problems, 
and also in their parents. The clinician needs to genuinely feel at ease with girls and be able to 
communicate well with her patients and the parents or caregivers. The clinician should help to 
enhance family communication while assuring confidentiality when requested around personal 
issues. 
The clinician should establish rapport by listening and displaying interest.  
It is important but not always easy to establish rapport with a girl during the first visit or several 
visits. Listening closely to the girl can be a key to developing rapport, as is demonstrating concern 
and interest with a non-judgemental attitude. The adolescent should also have time to ask 
questions. 
The clinician should ensure confidentiality.  
It is critical to insure a sense of confidentiality with any patient, but most particularly with a girl. 
The clinician should be familiar with those laws and regulations that cover consent and 
confidentiality among minors in their particular locality. The limits of confidentiality should also 
be discussed. Parents should also be aware of these confidentiality guidelines.  
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The clinician should act as an advocate.  
Because a girl may have had encounters with some adults who have been non-supportive, an 
opportunity presents itself for the clinician to stress the girl's positive attributes, characteristics and 
abilities. This is not the same as supporting high-risk behaviours.  
 
Guidelines for adult women 
Staff should be trained in how to deliver treatment to women with respect and empathy.  
Demonstrating respect and empathy towards women in every interaction is very much at the core 
of women-centred treatment (discussed above).  
Treatment needs to allow active and interdependent roles for women.  
Treatment in this context takes into account gender roles and female socialization. It does not 
allow sexual harassment while it supports active, interdependent roles for women. Treatment 
emphasizes mutuality and empathy and empowers women not with power over others but with 
power with others. Staff will also address women’s unique treatment issues, such as trauma, 
parenting skills, coping mechanisms, and self-worth. Women feel more able to share power for 
constructive, creative ends.  
 
4. Continuous treatment planning, from screening to 
discharge 
Before a patient can receive appropriate treatment, the presence and severity of the alcohol and/or 
drug disorders must be determined. Given that girls and women will very likely have multiple 
treatment needs that span physical, mental and social domains, screening is needed to identify the 
areas where help may be needed. Next, an assessment process is needed to determine the extent 
and the severity of any problem that was initially identified in any domain of the screening. The 
screening and assessment findings then form the basis of a personalized treatment plan to engage 
the patient into treatment and address her issues. The intensity and duration of treatment should be 
adequate to the patient’s needs. Numerous research studies support that patient outcomes are 
improved if the modality and intensity of treatment matches the intensity of her pre-treatment drug 
use and other psychosocial needs relative to every patient getting the same modality and level of 
treatment. Treatment planning needs to be a dynamic process, taking into account the severity of 
each problem that a patient has, as well as of each strength with which she presents to treatment. 
Deciding and reviewing treatment goals best proceeds as a cooperative and interactive process 
with the patient. Treatment planning needs to adjust as the patient progresses in treatment and 
discussions regarding where the patient will receive continued services once treatment is 
completed should be started well in advance of her discharge. 
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Guidelines for adolescent girls and adult women 
Programs need a plan to reach girls who cannot easily access care.  
For many locations in the world, women are a hidden and under-recognized population of people 
with drug use disorders. Women often find treatment by word of mouth from other women drug 
users. Thus, outreach from social workers and trusted community representatives can be helpful in 
reaching women to educate them about the treatment services available and to provide them with 
basic survival needs as they consider treatment options. In addition, outreach is often needed to be 
able to reach hidden populations such as girls, who may not be able to access or easily engage in 
structured forms of treatment. 
Screening and assessment methods are important for determining the need for and type 
of services for substance use disorders.  
Screening and assessment tools for substance use disorders and other mental health issues for 
women are available. These tools are also available for pregnant women. There are fewer reliable 
and valid screening and assessment measures for youth, including girls, than there are for adults, 
including women. Screening and assessment tools only for girls do not appear to be available. 
When possible and appropriate, the girl’s parents or caretakers should be present at her initial 
clinical interview. Their presence enables the counsellor to establish the rules of confidentiality 
(including that reports of abuse, neglect, or threats of harm to self or others must be disclosed), 
obtain early development history, and assess family dynamics. Subsequently, a private interview 
with the adolescent is important to facilitate a strong treatment alliance and elicit candid 
information about substance use and behaviour problems that the patient may not be comfortable 
disclosing with parents present. 
Consider the unintended consequences of labelling with diagnoses.  
Even more than with boys and men, there may be unintended consequences of diagnosis of 
substance use disorders and other co-morbid issues with women in that these labels may place 
them at risk for harm in other areas of their life including family and others close to them. Being 
identified as a drug user may also jeopardize the parental rights of women regarding their children 
as well as any current employment. Although this might not be always the case, this consideration 
should be kept in mind.  
Take the time needed to build rapport and a solid trusting relationship 
Engaging girls in treatment requires rapport to be built between a girl or a woman and the health 
professional. She must trust that care will be given in a professional, confidential and respectful 
manner. Girls and women are more likely to engage in treatment if the health care provider shows 
empathy and therapeutic alliance with her. Further, providing women-centred care (described 
above) will increase the likelihood that women will engage and continue in treatment. 
Empowering increases the chances of a successful outcome 
Treatment planning with girls and women is more likely to be successful when they are active 
partners in setting goals and have a voice in their course of treatment. Treatment planning needs to 
be a cooperative, collaborative effort between the girl/ woman and her provider; she needs 
feedback and the opportunity to change treatment planning aspects that are not working for her. 
Retention in treatment will be most likely to occur if the she feels empowered by the treatment 
staff to make life changes.  
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Start thinking and preparing for discharge well before the expected last day of treatment.  
Discharge planning needs to start early so that the patient is well prepared to leave the treatment, 
put her new life skills to use, and have a smooth transition into their community. 
 
5. Address issues over and beyond substance use disorder, in 
particular history of abuse and psychiatric co-morbidity 
Compared to boys and men with substance use disorders, girls and women with substance use 
disorders tend to have greater medical, childhood, lifetime and/or current trauma and interpersonal 
violence histories, as well as more current mental/psychological and social problems. Thus, these 
multiple domains need to be considered as a part of complete treatment. While this document is 
focused on a discussion of issues related to being an adolescent girl or woman, it is also critically 
important that treatment be appropriate for a patient’s developmental stage in life, as well as 
sensitive to such potentially important characteristics such as her ethnicity and culture, family 
history, and sexual orientation. 
 
Guidelines for adolescent girls 
Emotional and physical neglect and/or emotional, physical and sexual abuse are very 
likely in girls with substance use disorders and these issues must be concurrently treated.  
As noted in the introduction, substance use disorders occur in the context of complex life issues. 
These issues can include poverty, deprivation, poor nutrition, in the midst of environmental 
disparity (e.g., no access to clean water), exposure to multiple forms of violence, forced work or 
forced exclusion and untreated comorbid psychiatric disorders. For girls, there must be a keen 
awareness of possible childhood and/or current trauma in terms of emotion and physical neglect or 
emotional, physical and sexual abuse. These issues needs to be treated concurrently and integrated 
into the substance use disorder treatment and not in parallel. 
An integrated treatment strategy to treat the substance use disorder concurrent with the 
co-morbid psychiatric issues is important for improving treatment outcome. Co-morbid 
psychiatric issues of ADHD, depression, bipolar disorder, anxiety disorders and eating 
disorders are prevalent in girls with substance use disorders.  
Until very recently, little was known about the safety and efficacy of medications for treatment of 
psychiatric disorders in adolescents with substance use disorders or the potential for adverse 
interactions with used drugs. Thus, clinicians have been understandably reluctant to treat 
psychiatric disorders with medications in this population, often referring youths for substance use 
treatment before considering treatment of psychiatric co-morbidity. This sequential approach is 
cautious, but it perpetuates a clinical conundrum. Treatment for the co-morbid disorder is withheld 
pending successful drug treatment and achievement of abstinence, but the untreated psychiatric 
illness significantly diminishes the likelihood of successful drug treatment. While caution is 
reasonable and abstinence ideal before initiation of pharmacotherapy for a co-morbid disorder, 
treatment risks must be balanced against the potential consequences of leaving psychiatric illness 
untreated. Although there is not yet consensus on “best practices” for the use of medications to 
treat co-morbid disorders for adolescents’ dual diagnosis, these recent advances offer preliminary 
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evidence for an integrated treatment strategy, moving current practice standards forward until 
research can guide further refinement. 
Bipolar disorder can be treated while the girl is in treatment for substance use disorders.  
Data with adolescent girls and boys supports treating bipolar disorder in the context of concurrent 
treatment for substance use disorders. 
Adolescent girls with severe depression often need to receive both psychotherapy and 
pharmacotherapy.  
Current practice guidelines recommend that adolescents with severe depression receive both 
psychotherapy and pharmacotherapy, while those with mild or moderate symptoms may be offered 
a trial of psychotherapy alone before medications are considered (Birmaher, Brent, & Benson, 
1998). Both cognitive behavioural therapy and interpersonal psychotherapy have demonstrated 
efficacy for depression in adolescents without substance use disorders (Birmaher et al., 1998). 
Cognitive behavioural therapy may also be helpful in treating anxiety disorders, including 
posttraumatic stress disorder, in this adolescent girl population (Najavits, 2003). Medications to 
treat anxiety disorders in substance abusing adolescents has not been well studied. However, some 
girls may benefit from medication treatment of anxiety disorders in dually diagnosed adolescents 
in conjunction with substance use disorders treatment, given the available data (from previously 
mentioned depression studies) that fluoxetine (an SSRI) appears to have a favourable safety profile 
even in adolescents who use drugs (Lohman, Riggs, Hall, Mikulich, & Klein, 2002). 
 
Guidelines for adult women 
Women need a holistic approach that includes addressing physical and mental health. 
Like girls with substance use disorders, women face many of the same challenges. There is a need 
to focus on a holistic approach to include both survival needs, basic health care, gynaecological 
and psychological health as well as recovery from trauma (childhood and current), the ability to 
become economically independent, live in safe housing, establish and maintain healthy 
relationships and provide nurturing care for children. Build good working relationships with a 
comprehensive list of community services. Referrals to other specialised and general services may 
be needed. 
 
6. Include interactive skills training and practice to improve 
self-efficacy and competence  
Outcomes for treatment of alcohol and/or substance use disorders will be improved if women are 
given both knowledge of and support to change their substance use behaviour, as well as the 
knowledge and opportunity to practice skills related to reducing other risky behaviour and problem 
areas in their lives. With skills practice in a safe environment, girls and women may gain self-
efficacy, the belief that they can make meaningful changes in their lives, and the confidence and 
competence to make these changes.  
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Girls need developmentally appropriate positive models and practice of skills such as conflict 
negotiation, communication, drug refusal skills, and risky behaviour reduction. Providing 
homework outside of the treatment day can also reinforce skills. The homework used in cognitive-
behavioural therapy has also been an active ingredient for reducing substance use among women. 
In addition, women deserve to have accurate information about sexual and reproductive health and 
the materials and skills to protect themselves. Women have been shown to benefit from learning 
new knowledge and practicing skills such as condom use to reduce risky sexual behaviour.  
 
7. Recognize and address the unique needs of women during 
pregnancy and the post-partum period  
While the vast majority of girls and women who enter treatment for alcohol and/or drug use 
disorders during pregnancy were using substances before they became pregnant, pregnancy can be 
a time that adolescent girls or women may be open to receiving treatment for their substance use 
disorder due to their concern over the health of the unborn child. For in-depth guidance on the 
management of substance use disorders during pregnancy, the reader is referred to the recently 
published guidelines by WHO (WHO, 2014). 
A pregnant adolescent girl or woman should receive prenatal care and not be forced to terminate 
her pregnancy or feel stigmatized by any health care provider. Pregnant girls and women should be 
offered counselling if they do not want to end a pregnancy. For pregnant girls and women, the 
stigma of having a substance use disorder, the fear of losing custody of her child, and the threat of 
incarceration and/or being mandated to enter treatment often pose insurmountable barriers to her 
seeking treatment. Creating a treatment environment that is welcoming, non-judgmental, and 
supportive is essential to overcoming such barriers.  
A pregnant adolescent girl or woman deserves to receive treatment that matches the severity of her 
alcohol and/or drug use disorder. For heroin, opiate, opium and prescription-opioid-dependent 
patients, methadone and buprenorphine pharmacotherapy have been shown to improve maternal 
and infant outcomes compared to no treatment for the substance use disorder. In most cases, 
detoxification from opioids followed by no medication or the tapering of methadone or 
buprenorphine will result in relapse to opioid use unless patients have strong psychosocial 
resources and high motivation to remain opioid-free. In any case, programmes should expect that 
poly-drug use is the norm, not the exception and treat multiple drug use in an integrated manner. 
Although there are medical complications associated with specific drugs, it is rare that a pregnant 
woman’s substance use disorder will include only one drug. As a result, there are both multiple 
medical risks and cumulative medical risks due to concomitant substance use and these need to be 
taken into account.  
In addition to medical care, patients will need specific educational information about several 
issues. It is helpful to discuss with the patient the scope of prenatal care in terms of what to expect 
at each visit and the reasons for certain procedures and tests. The discussion should also include 
the specific risks of substance use and particularly drug interactions (e.g., methadone and 
benzodiazepines). Prenatal health education should be provided through classes conducted by 
nursing staff, videos, and/or printed booklets. Any printed materials must be written at the 
appropriate reading level for patients. Opioid-dependent pregnant patients should have a thorough 
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understanding of the risks and benefits of medication-assisted treatment in pregnancy. The 
adequacy of the methadone or buprenorphine dose should be discussed so that the patient 
understands the difference between symptoms of withdrawal and normal discomforts of 
pregnancy; how a therapeutic dose varies for each individual so that the appropriate dose for her 
may differ from that of her fellow patients; how her dose may need to be increased as her 
pregnancy progresses; how to recognize foetal stress if she begins to experience withdrawal; and 
the risk to both her and her foetus of continued substance use. She should understand that upon 
delivery her opioid agonist medication dose may need to be tapered down, and she should request 
a decrease if she feels overly sedated. Patients being treated for substance use disorders have a 
great deal of misinformation about sexuality, pregnancy, labour and delivery, birth control, and 
breastfeeding. Education about these aspects of care can be provided individually or in group 
formats.  
Great care needs to be taken in ensuring that girls and women are informed about any medical 
procedure before it occurs giving them power and decision making can help avoiding re-
traumatizing those who have a history of victimization. Pain management during labour and 
delivery needs to be taken seriously as many individuals with substance use disorders have 
increased sensitivity for pain. For opioid users, they may need more pain medication to achieve 
pain relief than their non-opioid using counterparts. For prenatally opioids exposed babies, they 
should be evaluated for neonatal opioid withdrawal and a protocol needs to be in place for 
assessing and treating such babies. Recent research has also found that mothers and babies have 
better outcomes if the mother and baby are kept together and not separated due to neonatal opioid 
withdrawal monitoring or treatment. 
 
Guidelines for adolescent girls and adult women 
Pregnancy in adolescence requires special care 
Girls are at higher risk of obstetrical problems than women Moreover, even more so than in the 
case of adult women, they need to be prepared for labour and delivery, as well as about caring for 
themselves and their baby before and after birth. 
Programs should have a good working relationship with social and child protective 
services.  
The legal framework and the organisation of services for the protection of children can vary 
greatly globally and drug treatment and care programs and staff must always be clear of their 
responsibilities as health care providers in this respect. In this context, and as appropriate, they 
should provide the support, clinical services, and referrals necessary to eliminate or reduce the 
chances that the mother will need to be reported to child protective services. 
Pregnant girls and women with substance use disorders should not be turned away from 
obstetrical care.  
Obstetrical complications that occur in pregnant girls and women with substance use disorders are 
similar to those observed in pregnant women who do not receive prenatal care, such as 
spontaneous abortion, stillbirth, placental insufficiency, intrauterine growth retardation, premature 
labour/delivery, premature rupture of membranes, anaemia, preeclampsia, and abruptio placentae 
(Curet & Hsi, 2002; Finnegan, 1979). Therefore, pregnant girls women with substance use 
disorders must receive appropriate screening and assessment. They must be engaged in treatment 
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services as early in gestation as possible, and treatment programs must provide coordinated 
services that include both prenatal care and substance use treatment.  
Obstetrical and drug treatment services are most beneficial for girls and women when 
they are provided in an integrated manner.  
Coordinated services can be provided in different settings: prenatal and obstetrical care can be 
integrated within a comprehensive substance use treatment program (Finnegan, Hagan, & 
Kaltenbach, 1991), or substance use treatment can be part of a comprehensive perinatal care 
program for women in treatment for substance use disorders (Curet & Hsi, 2002).  
 
8. Adapt the delivery of treatment to the ethnic, cultural, and 
socio-economic context of the patient  
Drug treatment for girls and women has a greater opportunity to be effective if it is adapted to the 
local situation and circumstances of girls and women in the local community. While there are 
many different treatment modalities and evidence-based approaches available, these methods need 
at least minimal adaptation to be accepted, utilized, and effective in different treatment contexts.  
Great care needs to be taken in both the selection of treatment modalities and evidence-based 
approaches, as well as how the methods are refined for the local situations and circumstances. A 
careful, sensitive and thorough process of verification needs to be undertaken to ensure that any 
adaption of a treatment still retains the essential elements of that evidence-based intervention and 
that this adapted treatment meets the actual needs of the girls and women.  
Girls and women who are ethnic minorities may encounter additional barriers when accessing 
substance use disorder treatment services, including language difficulties and or incompatible 
aspects of treatment with religious or spiritual practices. Ethnic, cultural, and religious diversity 
needs to be taken into consideration when providing treatment. Cultural mediators may need to be 
involved as outreach for these patients in order to help them in attending and engaging in 
treatment. 
 
Guidelines for adolescent girls and women 
Consideration of the ethnic and cultural status of girls and women and honouring and integrating 
these aspects into their care may help increase treatment engagement, especially in the case of girls 
and women who belong to ethnic minorities. For example, using traditional stories or learning 
about the traditions or history of her culture or ethnicity. 
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9. Include frequent and systematic monitoring and evaluation 
components 
It is the treatment program’s responsibility to ensure that quality care is being provided to patients. 
Evaluation and feedback on service and system performance for quality is needed from the staff, 
the patients and the larger community. A regular monitoring and evaluation system is needed 
because the types of drugs and consequences of drug use change over time as does the patient 
population seeking treatment. Thus, programs need to keep current with changing trends in drug 
use patterns and psychosocial functioning to best meet patient needs. 
 
Guidelines for adolescent girls and women 
Treatment for girls and women needs to include feedback from them about the process 
and experience of treatment.  
Girls and women should be given opportunities to provide feedback about the program in a safe 
way where there is no fear of negative consequences based on a negative evaluation of the 
program. Conducting focus groups, in-depth interviews or surveys about the likes and dislikes and 
satisfaction with services as well as suggestions for improvement can help the treatment program 
stay current in providing what patients need.  
Adolescents in particular can benefit from concrete feedback and monitoring.  
Girls are often very relational in their life orientation and having the chance to see how they are 
progressing in treatment, getting praise or gentle corrective feedback about what can be done in 
the future can help her modify future behaviour. 
Adolescents in particular can provide useful information for the planning of treatment 
services.  
Asking girls about the latest drug trends, how drugs are being used, what drugs are being used, 
what new trends they are seeing can help the treatment system prepare for new emerging drugs 
which may require different treatment responses. 
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